Production (Stage)
VentriPoint Diagnostics Ltd.
VPT.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 47.30K | 22.40K | -- | 30.40K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 47.30K | 22.40K | -- | 30.40K |
| Cost of Revenue | -- | -- | -- | -- | 0.00 |
| Gross Profit | 0.00 | 47.30K | 22.40K | -- | 30.40K |
| SG&A Expenses | 614.10K | 724.40K | 814.30K | 716.40K | 787.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 751.10K | 922.70K | 1.03M | 870.40K | 942.60K |
| Operating Income | -751.10K | -875.40K | -1.01M | -870.40K | -912.20K |
| Income Before Tax | -816.60K | -917.30K | -1.04M | -882.20K | -909.30K |
| Income Tax Expenses | -59.60K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -757.00K | -917.30K | -1.04M | -882.20K | -909.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -757.00K | -917.30K | -1.04M | -882.20K | -909.30K |
| EBIT | -751.10K | -875.40K | -1.01M | -870.40K | -912.20K |
| EBITDA | -751.10K | -875.40K | -1.01M | -869.70K | -911.30K |
| EPS Basic | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 161.30M | 157.48M | 157.18M | 157.14M | 156.82M |
| Average Diluted Shares Outstanding | 161.30M | 157.48M | 157.18M | 157.14M | 156.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |